Home › NDC Lookup › Ingredients › Docusate Sodium › 46122-0693-78
Good Neighbor Stool Softener laxative DOCUSATE SODIUM 250 mg Capsule, Liquid Filled, 100-count — NDC 46122-0693-78 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Good Neighbor Stool Softener laxative DOCUSATE SODIUM 250 mg Capsule, Liquid Filled, 100-count — NDC 46122-693-78 (Billing 46122-0693-78)

by AmerisourceBergen Drug Corp · 100 CAPSULE, LIQUID FILLED in 1 BOTTLE

This is a package of 100 capsules of Good Neighbor Stool Softener laxative DOCUSATE SODIUM 250 mg Capsule, Liquid Filled from AmerisourceBergen Drug Corp, marketed since Jul 2021 and currently FDA-listed; retail pharmacies pay about $0.0523 per capsule (NADAC). It is this product's only package size.

NDC 46122-0693-78
🏷️ FDA NDC (as labeled) 46122-693-78 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 46122-693-78 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
46122 labeler · 693 product · 78 package
Package marketed since
Jul 13, 2021
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
100 EA per package
Barcode (UPC)
0087701434044
Medicaid fills, this package
3,092 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 46122-693-78
Product NDC 46122-693
11-digit billing NDC 46122069378
NCPDP billing unit EA — each (per item)
RxCUI 1245468
UNII F05Q2T2JA0
UPC 0087701434044
Application # M007
SPL Set ID d09151ae-1cc6-4e69-8d80-7813082a4236
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2021-07-13
Route ORAL
Dosage form CAPSULE, LIQUID FILLED
Substance DOCUSATE SODIUM

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46500010300120
GPI class GNP Stool Softener
GCN Seq No 003011
GCN 09102
HICL code 001326
Ingredient (HICL) Docusate Sodium
HIC1 code D
Therapeutic class — broad (HIC1) Biliary System/Gastro-Intestinal System
HIC2 code D6
Therapeutic class — intermediate (HIC2) Drugs Acting Principally On The Colon
HIC3 code D6S
Therapeutic class — specific (HIC3) Laxatives And Cathartics
AHFS code 56:12.00.00
AHFS class Cathartics And Laxatives
FDB label name GNP STOOL SOFTENER 250 MG SFGL
FDB brand name Stool Softener
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 003011
  • GCN: 09102
  • GPI-14 (Medi-Span): 46500010300120
  • HICL (First Databank): 001326
  • AHFS class code: 56:12.00.00
  • RxCUI (RxNorm): 1245468
Why two NDCs? The FDA registers this code as 46122-693-78 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 46122-0693-78. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Softeners, emollients class.

Drug family (ATC) Softeners, emollients
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name GNP STOOL SOFTENER 250 MG SFGL Ingredient Docusate Sodium
🧪 What is this product?

Good Neighbor Stool Softener is an over-the-counter liquid-filled capsule taken by mouth. It contains docusate sodium, a stool softener that is commonly used to help soften stools and make bowel movements easier. This product is marketed as an OTC monograph drug, meaning it is sold under established FDA rules for this category of laxative products rather than as an individually approved application.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eaPer package
Retail pharmacies payNADAC · weekly $0.052 $5.23 / 100 capsules
Medicaid paysCMS SDUD · 12 mo $0.1298 $12.98 / 100 capsules
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per ea) — tap or hover for the price & month
Jun 2022 Dec 2023 Mar 2026 Sep 2026 $0.055 $0.036
▲ Up 45% over the last 19 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
46122-0693-78 You're viewing this Main listing 100 CAPSULE, LIQUID FILLED in 1 BOTTLE 2021-07-13 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Stool Softener Laxative 250 mg 00904-7281-60 Major 100 capsules $0.052 — Availability likely —
Good Neighbor Stool Softener laxative 250 mgthis 46122-0693-78 AmerisourceBergen 100 capsules $0.052 — Availability likely —
Stool Softener 250 mg 46122-0826-74 Amerisource 100 capsules $0.052 — Availability likely —
Docusate Sodium 250 mg 50268-0268-15 AvPAK 1 capsule $0.052 — Availability likely —
Stool Softener 250 mg 70677-1096-01 Strategic 100 capsules $0.052 — Availability likely —
Preferred Stool Softener laxative 250 mg 10956-0781-00 Reese 140 capsules — — FDA listed —
Stool Softener Laxative 250 mg 17856-7281-01 ATLANTIC 1 capsule — — FDA listed —
Stool Softener Laxative Extra Strength 250 mg 36800-0568-10 TOP 100 capsules — — Discontinued —
Stool Softener 250 mg 36800-0640-10 TOP 100 capsules — — FDA listed —
H E B Stool Softener laxative 250 mg 37808-0293-88 H 140 capsules — — FDA listed —
Stool Softener 250 mg 37808-0585-14 HEB 140 capsules — — FDA listed —
Stool Softener 250 mg 37808-0879-14 H 140 capsules — — FDA listed —
Stool Softener 250 mg 37835-0223-01 Bi-Mart 100 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 41250-0859-10 MEIJER, 100 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 49035-0378-14 EQUATE 140 capsules — — Discontinued —
Prolaxa 250 mg 53225-2001-01 Terrain 100 capsules — — FDA listed —
Docusate Sodium 250 mg 53345-0035-01 Humanwell 7000 capsules — — FDA listed —
Docusate Sodium 250 mg 54629-0601-01 National 100 capsules — — FDA listed —
Docusate Sodium 250 mg 55154-4341-00 Cardinal 1 capsule — — Discontinued —
Stool Softener Extra Strength 250 mg 55910-0879-10 Dolgencorp, 100 capsules — — FDA listed —
Stool Softener 250 mg 57896-0426-01 Geri-Care 100 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 59726-0058-25 P 250 capsules — — FDA listed —
Stool Softener Laxative Extra Strength 250 mg 59726-0059-10 P 100 capsules — — FDA listed —
Stool Softener Laxative Extra Strength 250 mg 59726-0879-10 P 100 capsules — — FDA listed —
Quality Choice Stool Softener laxative 250 mg 63868-0662-01 Chain 100 capsules — — FDA listed —
Colace Extra Strength Stool Softner 250 mg 67618-0201-12 Atlantis 60 capsules — — FDA listed —
Stool Softener Laxative 250 mg 68016-0471-01 Chain 100 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 68016-0587-00 Chain 100 capsules — — FDA listed —
Stool Softener 250 mg 68071-5297-06 NuCare 60 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 69842-0740-25 CVS 250 capsules — — FDA listed —
Stool Softener Extra Strength 250 mg 69842-0879-25 CVS 250 capsules — — FDA listed —
Stool Softener 250 mg 71335-1677-01 Bryant 30 capsules — — FDA listed —
Docusate Sodium 250 mg 72789-0166-60 PD-Rx 60 capsules — — FDA listed —
Topcare Stool Softener laxative 250 mg 76162-0764-10 TOPCO 100 capsules — — FDA listed —
Stool Softener Laxative Extra Strength 250 mg 79903-0073-14 WALMART 140 capsules — — FDA listed —
Prolaxa 250 mg 80425-0540-01 Advanced 100 capsules — — FDA listed —
Docusate Sodium, Extra Strength 250 Mg 80513-0100-01 Advanced 100 capsules — — FDA listed —
Docusate Sodium, Extra Strength 250 Mg 80513-0101-01 Advanced 100 capsules — — FDA listed —
Stool Softener Laxative 250 mg 71335-2313-01 Bryant 30 capsules — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2021
On the market since
Jul 2021
📍
2026
Currently FDA-listed
5 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerAmerisourceBergen Drug Corp
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code46122
First marketedJul 2021
Product typeHuman Otc Drug
Portfolio13 products on file

More NDCs from AmerisourceBergen Drug Corp labeler code 46122

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children
🎯 Indications and Usage 15 words ▾

Uses relieves occasional constipation (irregularity) generally produces a bowel movement in 12 to 72 hours

⏱️ Dosage and Administration 50 words ▾

Directions Take only by mouth. Doses may be taken as a single daily dose or in divided doses. adults and children 12 years and over take 1 to 3 softgels daily children 2 to under 12 years of age take 1 softgel daily children under 2 years ask a doctor

⚠️ Warnings 118 words ▾

Warnings Do not use if you are presently taking mineral oil, unless told to do so by a doctor Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel movements that lasts over 2 weeks Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. you need to use a stool softener laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 24 words ▾

Other information each softgel contains: sodium 5 mg VERY LOW SODIUM store at room temperature 15°-30°C (59°-86°F) and avoid excessive heat Image of carton

🧪 Active Ingredient 9 words ▾

Active ingredient (in each softgel) Docusate Sodium 250 mg

🧪 Inactive Ingredients 23 words ▾

Inactive Ingredients D&C Red No. 33, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, glycerol, Polyethylene glycol, purified water, sorbitol, titanium dioxide

🎯 Purpose 3 words ▾

Purpose Stool softener

📄 Do Not Use 18 words ▾

Do not use if you are presently taking mineral oil, unless told to do so by a doctor

📄 Ask a Doctor Before Use If 24 words ▾

Ask a doctor before use if you have stomach pain nausea vomiting noticed a sudden change in bowel movements that lasts over 2 weeks

📄 Stop Use and Ask a Doctor If 44 words ▾

Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative. These could be signs of a serious condition. you need to use a stool softener laxative for more than 1 week

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
3.1K
Units reimbursed last 4 qtrs
247.2K
Gross reimbursed last 4 qtrs
$32.1K
Avg / prescription
$10.38
Avg / unit
$0.1298
Latest quarter Q1 2026
665Rx
Medicaid pays / ea
$0.1298
gross reimbursed
vs
NADAC / ea
$0.0523
acquisition cost
=
Spread
+$0.0775
+148% vs cost
What Medicaid paid per ea (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
91% FFS
Fee-for-service · 2,821 Rx Managed care · 271 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: no data reported WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: no data reported MN Wisconsin: no data reported WI Michigan: no data reported MI New York: 1,020 units · 5.2 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 6,944 units · 164 per 100k residents OR Nevada: 690 units · 21.6 per 100k residents NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: no data reported IN Ohio: no data reported OH Pennsylvania: no data reported PA New Jersey: no data reported NJ Massachusetts: no data reported MA California: 230,491 units · 592 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: no data reported MO Kentucky: 8,077 units · 178 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: no data reported AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: no data reported TX Florida: no data reported FL
Units reimbursed · per 100k residents
5.2592
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 California 592 /100k
2 Kentucky 178 /100k
3 Oregon 164 /100k
4 Nevada 21.6 /100k
5 New York 5.2 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.
← 46122-0692-72 · AmerisourceBergen 46122-0694-65 · AmeriSource →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.